Chondroitin Sulfate as a Structure-Modifying Agent

Advances in Pharmacology

Volumn 53, Issue , 2006, Pages 475-488

  Uebelhart, Daniel ^a,b   Knols, Ruud ^a   de Bruin, Eling D ^a,c   Verbruggen, Gust ^d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c ETH ZURICH   (Switzerland)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; INTERLEUKIN 1;

CARTILAGE CELL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FINGER JOINT; HUMAN; KNEE; OSTEOARTHRITIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CHONDROCYTES; CHONDROITIN SULFATES; FINGER JOINT; HUMANS; INTERLEUKIN-1; KNEE JOINT; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIALS;

EID: 33846165503     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(05)53024-2     Document Type: Review

References (45)

1. Altman R.D., Hochberg M.C., Moskowitz R.W., and Schnitzer T.J. Recommendations for the medical management of osteoarthritis of the hip and knee. 2000 update. ACR subcommittee on osteoarthritis guidelines. Arthritis Rheum. 43 (2000) 1905-1915
2. Brandt K.D., Mazzuca S.A., Katz B.P., Lane K.A., Buckwalter K.A., Yocum D.E., Wolfe F., Schnitzer T.J., Moreland L.W., Manzi S., Bradley J.D., Sharma L., et al. Effects of doxycycline on progression of osteoarthritis: Results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum. 52 (2005) 2015-2025
3. Brennan J.J., Aherne F.X., and Nakano T. Effects of glycosaminoglycan polysulfate treatment on soundness, hyaluronic acid content of synovial fluid and proteoglycan aggregate in articular cartilage of lame boars. Can. J. Vet. Res. 51 (1987) 394-398
4. Buckland-Wright J.C. Quantitative radiography of osteoarthritis. Ann. Rheum. Dis. 53 (1994) 268-275
5. Buckland-Wright J.C., MacFarlane D.G., Lynch J.A., Jasani M.K., and Bradshaw C.R. Joint space width measures cartilage thickness in osteoarthritis of the knee: High resolution plain film and double contrast macroradiographic investigation. Ann. Rheum. Dis. 54 (1995) 263-268
6. Carreno M.R., Muniz O.E., and Howell D.S. The effect of glycosaminoglycan polysulfuric acid ester on articular cartilage in experimental osteoarthritis: Effects on morphological variables of disease severity. J. Rheumatol. 13 (1986) 490-497
7. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O'Dell J.R., Hooper M.M., Bradley J.D., Bingham III C.O., Weisman M.H., Jackson C.G., Lane N.E., Crush J.J., et al. Glucomine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N. Eng. J. Med. 23 (2006) 795-808
8. Committee for Proprietary Medicinal Products (CPMP). Points to consider on clinical investigation of medicinal products used in the treatment of osteoarthritis (1998), European Agency for the Evaluation of Medicinal Products, London
9. Dickersin K., Scherer R., and Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 309 (1994) 1286-1291
10. Dieppe P. Disease modification in osteoarthritis: Are drugs the answer?. Arthritis Rheum. 52 (2005) 1956-1959
11. Eylau O. Intra-articular heparin therapy of genuine arthrosis deformans of the knee joint. Med. Klin. 54 (1959) 145
12. Eylau O. On the pathogenesis and causal treatment of arthrosis of the knee joint. Med. Klin. 55 (1960) 2367-2370
13. Francis D.J., Hutadilok N., Kongtawelert P., and Ghosh P. Pentosan polysulphate and glycosaminoglycan polysulphate stimulate the synthesis of hyaluronan in vivo. Rheumatol. Int. 13 (1993) 61-64
14. Kalbhen D.A. Experimental confirmation of the antiarthritic activity of glycosaminoglycan polysulfate. Z. Rheumatol. 42 (1983) 178-184
15. Kellgren J.H., and Lawrence J.S. Radiological assessment of osteoarthritis. Ann. Rheum. Dis. 16 (1957) 494-501
16. Kosher R.A., Lash J.W., and Minor R.R. Environmental enhancement of in vitro chondrogenesis. Dev. Biol. 35 (1973) 210-220
17. Lequesne M. Chondrometry: Quantitative evaluation of joint space width and rate of joint space loss in osteoarthritis of the hip. Rev. Rhum. Engl. Ed. 62 (1995) 155-158
18. Listrat V., Ayral X., Paternello F., Bonvarlet J.P., Simonnet J., Amor B., and Dougados M. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 5 (1997) 153-160
19. Mazzuca S.A., Brandt K.D., Buckwalter K.A., and Lequesne M. Pitfalls in the accurate measurement of joint space narrowing in semiflexed, anteroposterior radiographic imaging of the knee. Arthritis Rheum. 50 (2004) 2508-2515
20. Michel B.A., Stucki G., Frey D., De Valthaire F., Vignon E., Bruehlmann P., and Uebelhart D. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: A randomized, controlled trial. Arthritis Rheum. 52 (2005) 779-786
21. Momburg M., Stuhlsatz H.W., Vogeli H., Vojtisek O., Eylau O., and Greiling H. Clinical chemical changes in the synovial fluid following intra-articular injection of a glycosaminoglycan polysulfate. Z. Rheumatol. 35 Suppl. 4 (1976) 389-390
22. Muller W., Panse P., Brand S., and Staubli A. In vivo study of the distribution, affinity for cartilage and metabolism of glycosaminoglycan polysulphate (GAGPS, Arteparon). Z. Rheumatol. 42 (1983) 355-361
23. Nevo Z., Horwitz A.L., and Dorfman A. Synthesis of chondromucoprotein by chondrocytes in suspension culture. Dev. Biol. 28 (1972) 219-228
24. Nevo Z., and Dorfman A. Stimulation of chondromucoprotein synthesis in chondrocytes by extracellular chondromucoprotein. Proc. Natl. Acad. Sci. USA 69 (1972) 2069-2072
25. Piperno M., Hellio le Graverand M.P., Conrozier T., Conrozier T., Bochu M., Mathieu P., and Vignon E. Quantitative evaluation of joint space width in femorotibial osteoarthritis: Comparison of three radiographic views. Osteoarthritis Cartilage 6 (1998) 252-259
26. Richy F., Bruyere O., Ethgen O., Cucherat M., Henrotin Y., and Reginster J.Y. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: A comprehensive meta-analysis. Arch. Intern. Med. 163 (2003) 1514-1522
27. Sadowski T., and Steinmeyer J. Effects of polysulfated glycosaminoglycan and triamcinolone acetonid on the production of proteinases and their inhibitors by IL-1alpha treated articular chondrocytes. Biochem. Pharmacol. 64 (2002) 217-227
28. Schwartz N.B., and Dorfman A. Stimulation of chondroitin sulfate proteoglycan production of by chondrocytes in monolayer. Connec. Tissue Res. 3 (1975) 115-122
29. Tung J.T., Venta P.J., and Caron J.P. Inducible nitric oxide expression in equine articular chondrocytes: Effects of antiinflammatory compounds. Osteoarthritis Cartilage 10 (2002) 5-12
30. Uebelhart D., Thonar E.J., Zhang J., and Williams J.M. Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit. Osteoarthritis Cartilage 6 Suppl. A (1998) 6-13
31. Uebelhart D., Thonar E.J., Delmas P.D., Chantraine A., and Vignon E. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: A pilot study. Osteoarthritis Cartilage 6 Suppl. A (1998) 39-46
32. Uebelhart D., Malaise M., Marcolongo R., DeVathaire F., Piperno M., Mailleux E., Fioravanti A., Matoso L., and Vignon E. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: A one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage 12 (2004) 269-276
33. Verbruggen G., and Veys E.M. Influence of sulphated glycosaminoglycans upon proteoglycan metabolism of the synovial lining cells. Acta Rheumatol. 1 (1977) 75-92
34. Verbruggen G., and Veys E.M. Influence of an oversulphated heparinoid upon hyaluronate metabolism of the human synovial cell in vivo. J. Rheumatol. 6 (1979) 554-561
35. Verbruggen G., and Veys E.M. Intra-articular injection of pentosanpolysulphate results in increased hyaluronan molecular weight in joint fluid. Clin. Exp. Rheumatol. 10 (1992) 249-254
36. Verbruggen G., and Veys E.M. Numerical scoring systems for the anatomical evolution of osteoarthritis of the finger joint. Arthritis Rheum. 39 (1996) 308-320
37. Verbruggen G., and Veys E.M. Influence of chondroitin 4&6 sulfate on finger osteoarthrites in a double blind, controlled study versus placebo. Litera Rheumatol. 24 (1998) 43-47
38. Verbruggen G., Goemaere S., and Veys E.M. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis Cartilage 6 Suppl. A (1998) 37-38
39. Verbruggen G., Cornelissen M., Elewaut D., Broddelez C., De Ridder L., and Veys E.M. Influence of polysulfated polysaccharides on aggrecans synthesized by differentiated human articular chondrocytes. J. Rheumatol. 26 (1999) 1663-1671
40. Verbruggen G., Goemaere S., and Veys E.M. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin. Rheumatol. 21 (2002) 231-243
41. Verdonk P., Wang J., Elewaut D., Broddelez C., Veys E.M., and Verbruggen G. Cyclodextrin polysulphates enhance human chondrocyte extracellular matrix repair. Osteoarthritis Cartilage (2006) (In press)
42. Vignon E., Conrozier T., Piperno M., Richard S., Carrillon Y., and Fantino O. Radiographic assessment of hip and knee osteoarthritis. Recommendations: Recommended guidelines. Osteoarthritis Cartilage 7 (1999) 434-436
43. Volpi N. Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers. Osteoarthritis Cartilage 10 (2002) 768-777
44. Volpi N. Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers. Osteoarthritis Cartilage 11 (2003) 433-441
45. Wang L., Wang J., Almqvist K.F., Veys E.M., and Verbruggen G. Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro. Clin. Exp. Rheumatol. 20 (2002) 669-676